Miriam Kelly

Miriam Kelly serves as a Senior Health Scientist, providing critical scientific and technical oversight for health-related acquisitions within her agency. In this role, she evaluates complex biomedical and public health requirements, ensuring that procurement decisions align with evidence-based standards and regulatory compliance. She plays a pivotal role in shaping solicitation language, assessing technical proposals, and advising contracting personnel on scientific validity, clinical relevance, and operational feasibility of proposed solutions. Her acquisitions typically encompass research services, diagnostic technologies, epidemiological tools, and public health infrastructure support, bridging the gap between scientific innovation and operational procurement. While no specific contractor relationships are identified, her procurement pattern suggests collaboration with a broad spectrum of vendors, including academic research institutions, biotechnology firms, clinical trial organizations, and specialized health services providers. She engages with vendors capable of delivering high-integrity scientific deliverables, often requiring rigorous validation protocols and compliance with FDA, CDC, or NIH standards. Her working relationships are characterized by a focus on technical excellence, transparency, and adherence to scientific rigor rather than volume-based vendor loyalty. Miriam Kelly’s contracting profile reflects a strong preference for open competition, with 100% of her acquisitions classified as non-set-aside. This indicates a procurement strategy prioritizing technical merit and capability over socioeconomic classifications, though it does not preclude participation from small or disadvantaged businesses that meet stringent scientific criteria. Her approach emphasizes outcome-driven competition, where all vendors are evaluated equally on scientific merit, methodology, and delivery capacity. Her primary domain expertise lies in biomedical research, clinical diagnostics, public health surveillance, and health data analytics. She procures services and technologies aligned with NAICS categories including scientific research and development, medical laboratory services, and health informatics. Her technical focus centers on evidence-based interventions, laboratory instrumentation, data collection systems, and health outcome measurement tools critical to advancing population health initiatives.